223 related articles for article (PubMed ID: 26188115)
1. Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment.
Troutman JA; Rick DL; Stuard SB; Fisher J; Bartels MJ
Regul Toxicol Pharmacol; 2015 Nov; 73(2):530-43. PubMed ID: 26188115
[TBL] [Abstract][Full Text] [Related]
2. Prediction of tissue and urine concentrations of 2-phenoxyethanol and its metabolite 2-phenoxyacetic acid in rat and human after oral and dermal exposures via GastroPlus
Zhang F; LeBaron MJ; Marty MS
SAR QSAR Environ Res; 2022 May; 33(5):323-339. PubMed ID: 35301938
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of 2-phenoxyethanol and its major metabolite, phenoxyacetic acid, after dermal and inhaled routes of exposure: application to development PBPK model in rats.
Kwon M; Park JB; Kwon M; Song J; Yeo CS; Bae SH
Arch Toxicol; 2021 Jun; 95(6):2019-2036. PubMed ID: 33844041
[TBL] [Abstract][Full Text] [Related]
4. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation and toxicokinetics of 2-phenoxyethanol after oral exposure in humans: a volunteer study.
Eckert E; Jäger T; Hiller J; Leibold E; Bader M; Göen T
Arch Toxicol; 2024 Jun; 98(6):1771-1780. PubMed ID: 38668861
[TBL] [Abstract][Full Text] [Related]
6. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats.
Hays SM; Elswick BA; Blumenthal GM; Welsch F; Conolly RB; Gargas ML
Toxicol Appl Pharmacol; 2000 Feb; 163(1):67-74. PubMed ID: 10662606
[TBL] [Abstract][Full Text] [Related]
7. Physiologically based pharmacokinetic models applicable to organogenesis: extrapolation between species and potential use in prenatal toxicity risk assessments.
Welsch F; Blumenthal GM; Conolly RB
Toxicol Lett; 1995 Dec; 82-83():539-47. PubMed ID: 8597107
[TBL] [Abstract][Full Text] [Related]
8. A toxicokinetic study of inhaled ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human.
Gargas ML; Tyler TR; Sweeney LM; Corley RA; Weitz KK; Mast TJ; Paustenbach DJ; Hays SM
Toxicol Appl Pharmacol; 2000 May; 165(1):53-62. PubMed ID: 10814553
[TBL] [Abstract][Full Text] [Related]
9. Proposed occupational exposure limits for select ethylene glycol ethers using PBPK models and Monte Carlo simulations.
Sweeney LM; Tyler TR; Kirman CR; Corley RA; Reitz RH; Paustenbach DJ; Holson JF; Whorton MD; Thompson KM; Gargas ML
Toxicol Sci; 2001 Jul; 62(1):124-39. PubMed ID: 11399800
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetic model for chronic inhalation of 2-butoxyethanol.
Lee KM; Dill JA; Chou BJ; Roycroft JH
Toxicol Appl Pharmacol; 1998 Dec; 153(2):211-26. PubMed ID: 9878592
[TBL] [Abstract][Full Text] [Related]
11. Determination of age and gender differences in biochemical processes affecting the disposition of 2-butoxyethanol and its metabolites in mice and rats to improve PBPK modeling.
Corley RA; Grant DM; Farris E; Weitz KK; Soelberg JJ; Thrall KD; Poet TS
Toxicol Lett; 2005 Mar; 156(1):127-61. PubMed ID: 15705493
[TBL] [Abstract][Full Text] [Related]
12. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
13. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
Chou WC; Lin Z
Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
[TBL] [Abstract][Full Text] [Related]
14. Development of a physiologically based pharmacokinetic model for ethylene glycol and its metabolite, glycolic Acid, in rats and humans.
Corley RA; Bartels MJ; Carney EW; Weitz KK; Soelberg JJ; Gies RA; Thrall KD
Toxicol Sci; 2005 May; 85(1):476-90. PubMed ID: 15716482
[TBL] [Abstract][Full Text] [Related]
15. The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man.
Louisse J; de Jong E; van de Sandt JJ; Blaauboer BJ; Woutersen RA; Piersma AH; Rietjens IM; Verwei M
Toxicol Sci; 2010 Dec; 118(2):470-84. PubMed ID: 20833708
[TBL] [Abstract][Full Text] [Related]
16. Development of a physiologically based pharmacokinetic model for propylene glycol monomethyl ether and its acetate in rats and humans.
Corley RA; Gies RA; Wu H; Weitz KK
Toxicol Lett; 2005 Mar; 156(1):193-213. PubMed ID: 15705496
[TBL] [Abstract][Full Text] [Related]
17. Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans.
Corley RA; Bormett GA; Ghanayem BI
Toxicol Appl Pharmacol; 1994 Nov; 129(1):61-79. PubMed ID: 7974497
[TBL] [Abstract][Full Text] [Related]
18. A toxicokinetic study of inhaled ethylene glycol ethyl ether acetate and validation of a physiologically based pharmacokinetic model for rat and human.
Gargas ML; Tyler TR; Sweeney LM; Corley RA; Weitz KK; Mast TJ; Paustenbach DJ; Hays SM
Toxicol Appl Pharmacol; 2000 May; 165(1):63-73. PubMed ID: 10814554
[TBL] [Abstract][Full Text] [Related]
19. A stochastic whole-body physiologically based pharmacokinetic model to assess the impact of inter-individual variability on tissue dosimetry over the human lifespan.
Beaudouin R; Micallef S; Brochot C
Regul Toxicol Pharmacol; 2010 Jun; 57(1):103-16. PubMed ID: 20122977
[TBL] [Abstract][Full Text] [Related]
20. Approaches for applications of physiologically based pharmacokinetic models in risk assessment.
Thompson CM; Sonawane B; Barton HA; DeWoskin RS; Lipscomb JC; Schlosser P; Chiu WA; Krishnan K
J Toxicol Environ Health B Crit Rev; 2008 Aug; 11(7):519-47. PubMed ID: 18584453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
